Rudnick, Jonathan

Rudnick, Jonathan was paid $398K by Medicaid between Jan 2018 and Nov 2024, across 10 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 67% of everything it billed.

33Billing provider infoRUDNICK, JONATHAN
MIDDLETOWN, NY 10941

33aNPI1508958299assigned 09/29/2006

33bProvider typePhysical Medicine & Rehabilitation Physician

28Total paid$398K

24GClaims5,824

24DCodes billed10

24AFirst – last monthJan 2018 – Nov 2024

Compared with peers

Next to other Physical Medicine & Rehabilitation Physician providers in New York

Rank by total paid#53 of 465

Median peer was paid$12K

This provider vs. median33×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	478	$24K
2019	993	$74K
2020	952	$66K
2021	1,109	$98K
2022	1,082	$93K
2023	555	$27K
2024incomplete	655	$16K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	67%	3,307	3,298	$267K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	22%	1,495	1,475	$86K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	5.0%	319	319	$20K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	4.7%	166	166	$19K
99442		1.4%	93	92	$6K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	55	55	$622.53
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	42	42	$145.62
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	38	38	$116.30
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established)	<1%	235	235	$2.92
99080		0%	74	12	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.